Evidence map›Paper›PMID 38851721›Full record

ArticleNature communications2024

Chiral dinitrogen ligand enabled asymmetric Pd/norbornene cooperative catalysis toward the assembly of C-N axially chiral scaffolds.

Liang Jin, Ya Li, Yihui Mao, Xiao-Bao He, Zhan Lu, Qi Zhang, Bing-Feng Shi

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liang Jin *Department of Chemistry, Zhejiang University, Hangzhou, China.
Ya Li *Department of Chemistry, Zhejiang University, Hangzhou, China.
Yihui Mao *Department of Chemistry, Zhejiang University, Hangzhou, China.
Xiao-Bao HeZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, China.
Zhan LuDepartment of Chemistry, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-3069-079X
Qi ZhangDepartment of Chemistry, Zhejiang University, Hangzhou, China. qiqiyape@zju.edu.cn.ORCID http://orcid.org/0000-0001-9772-7203
Bing-Feng ShiDepartment of Chemistry, Zhejiang University, Hangzhou, China. bfshi@zju.edu.cn.ORCID http://orcid.org/0000-0003-0375-955X

Funding

China Postdoctoral Science Foundation 2023M733044National Natural Science Foundation of China (National Science Foundation of China) 21925109; U22A20388; 92256302National Natural Science Foundation of China (National Science Foundation of China) 22201249Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LD22B030003
6 · The paper itself

Abstract

C - N axially chiral compounds have recently attracted significant interest among synthetic chemistry community due to their widespread application in pharmaceuticals, advanced materials and organic synthesis. Although the emerging asymmetric Catellani reaction offers great opportunity for their modular and efficient preparation, the only operative chiral NBE strategy to date requires using half stoichiometric amount of chiral NBE and 2,6-disubstituted bromoarenes as electrophiles. We herein report an efficient assembly of C-N axially chiral scaffolds through a distinct chiral ligand strategy. The crucial chiral source, a biimidazoline (BiIM) chiral dinitrogen ligand, is used in relatively low loading and permits the use of less bulky bromoarenes. The method also features the use of feedstock plain NBE, high reactivity, good enantioselectivity, ease of operation and scale-up. Applications in the preparation of chiral optoelectronic material candidates featuring two C-N chiral axes and a chiral ligand for asymmetric C-H activation have also been demonstrated.

Identifiers

PMID38851721
PMCPMC11162495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.